New York Presbyterian Hospital-Weill Cornell Medical Center is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Hospital-Weill Cornell Medical Center has participated in 4 clinical trials.
Therapeutic areas: Pheochromocytoma, Paraganglioma, Alloimmune Thrombocytopenia.
Sponsors: Molecular Insight Pharmaceuticals, Inc., Weill Medical College of Cornell University, Proteon Therapeutics.
Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Hospital-Weill Cornell Medical Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Hospital-Weill Cornell Medical Center has 4 clinical trials on record. Their work covers Pheochromocytoma, Paraganglioma, Alloimmune Thrombocytopenia.
New York Presbyterian Hospital-Weill Cornell Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.